VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $63,911,034 | -9.2% | 2,374,992 | +1.6% | 0.09% | +8.3% |
Q2 2023 | $70,403,442 | -4.1% | 2,338,208 | +3.1% | 0.08% | -21.5% |
Q1 2023 | $73,384,325 | +6.1% | 2,268,449 | -6.0% | 0.11% | -7.0% |
Q4 2022 | $69,179,851 | -13.6% | 2,413,812 | -27.3% | 0.12% | -22.8% |
Q3 2022 | $80,081,344 | +1.1% | 3,320,108 | +14.8% | 0.15% | +8.0% |
Q2 2022 | $79,179,956 | -22.0% | 2,891,894 | +7.9% | 0.14% | -4.2% |
Q1 2022 | $101,566,770 | +406167.1% | 2,679,099 | +334787.4% | 0.14% | – |
Q4 2021 | $25,000 | +4.2% | 800 | 0.0% | 0.00% | – |
Q3 2021 | $24,000 | -11.1% | 800 | 0.0% | 0.00% | – |
Q2 2021 | $27,000 | +3.8% | 800 | 0.0% | 0.00% | – |
Q1 2021 | $26,000 | -10.3% | 800 | 0.0% | 0.00% | – |
Q4 2020 | $29,000 | -91.5% | 800 | -90.7% | 0.00% | -100.0% |
Q3 2020 | $340,000 | -14.1% | 8,595 | -22.0% | 0.00% | 0.0% |
Q2 2020 | $396,000 | +1984.2% | 11,018 | +1277.2% | 0.00% | – |
Q1 2020 | $19,000 | -17.4% | 800 | 0.0% | 0.00% | – |
Q4 2019 | $23,000 | – | 800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |